Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free SLXNW Stock Alerts

Silexion Therapeutics Corp - Warrant (SLXNW) Competitors

$0.02 0.00 (-10.96%)
As of 08/11/2026 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SLXNW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Silexion Therapeutics Corp - Warrant stock or one of its competitors? Silexion Therapeutics Corp - Warrant's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Silexion Therapeutics Corp - Warrant compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
Silexion Therapeutics Corp - WarrantN/AN/AN/AN/AN/A

In the previous week, Alvotech and Alvotech both had 2 articles in the media. Alvotech's average media sentiment score of 0.00 equaled Silexion Therapeutics Corp - Warrant'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Silexion Therapeutics Corp - Warrant Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Silexion Therapeutics Corp - Warrant N/A N/A N/A

Summary

Alvotech beats Silexion Therapeutics Corp - Warrant on 1 of the 1 factors compared between the two stocks.

How does Silexion Therapeutics Corp - Warrant compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, Apollomics had 1 more articles in the media than Silexion Therapeutics Corp - Warrant. MarketBeat recorded 3 mentions for Apollomics and 2 mentions for Silexion Therapeutics Corp - Warrant. Apollomics' average media sentiment score of 0.00 equaled Silexion Therapeutics Corp - Warrant'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Silexion Therapeutics Corp - Warrant Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Silexion Therapeutics Corp - WarrantN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Silexion Therapeutics Corp - Warrant N/A N/A N/A

Summary

Apollomics beats Silexion Therapeutics Corp - Warrant on 2 of the 2 factors compared between the two stocks.

How does Silexion Therapeutics Corp - Warrant compare to Aravive?

Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Silexion Therapeutics Corp - Warrant had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Silexion Therapeutics Corp - Warrant and 0 mentions for Aravive. Silexion Therapeutics Corp - Warrant's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Silexion Therapeutics Corp - Warrant Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silexion Therapeutics Corp - WarrantN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Silexion Therapeutics Corp - WarrantN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Aravive beats Silexion Therapeutics Corp - Warrant on 2 of the 3 factors compared between the two stocks.

How does Silexion Therapeutics Corp - Warrant compare to bioAffinity Technologies?

Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
Silexion Therapeutics Corp - WarrantN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silexion Therapeutics Corp - WarrantN/AN/AN/AN/AN/A
bioAffinity Technologies$5.61MN/AN/AN/AN/A

In the previous week, Silexion Therapeutics Corp - Warrant and Silexion Therapeutics Corp - Warrant both had 2 articles in the media. bioAffinity Technologies' average media sentiment score of 0.51 beat Silexion Therapeutics Corp - Warrant's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Silexion Therapeutics Corp - Warrant Neutral
bioAffinity Technologies Positive

Summary

bioAffinity Technologies beats Silexion Therapeutics Corp - Warrant on 2 of the 2 factors compared between the two stocks.

How does Silexion Therapeutics Corp - Warrant compare to BioVie?

Silexion Therapeutics Corp - Warrant (NASDAQ:SLXNW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

In the previous week, Silexion Therapeutics Corp - Warrant had 1 more articles in the media than BioVie. MarketBeat recorded 2 mentions for Silexion Therapeutics Corp - Warrant and 1 mentions for BioVie. Silexion Therapeutics Corp - Warrant's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Silexion Therapeutics Corp - Warrant Neutral
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
Silexion Therapeutics Corp - WarrantN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silexion Therapeutics Corp - WarrantN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Silexion Therapeutics Corp - Warrant beats BioVie on 1 of the 1 factors compared between the two stocks.

Get Silexion Therapeutics Corp - Warrant News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLXNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLXNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLXNW vs. The Competition

Export
MetricSilexion Therapeutics Corp - WarrantBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.71B$7.08B$12.96B
Dividend YieldN/A3.76%2.57%10.34%
P/E RatioN/A10.37268.4325.05
Price / SalesN/A1,283.27596.7789.48
Price / CashN/A102.5472.2650.42
Price / BookN/A17.9813.216.18
Net IncomeN/A-$13.23M$3.44B$347.05M
7 Day PerformanceN/A3.20%2.09%1.25%
1 Month PerformanceN/A-1.17%-0.23%-0.64%
1 Year PerformanceN/A59.41%70.30%20.12%

Silexion Therapeutics Corp - Warrant Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLXNW
Silexion Therapeutics Corp - Warrant
N/A$0.02
-8.7%		N/A-24.0%$0.00N/AN/AN/A
ALVOW
Alvotech
N/A$0.15
flat		N/A-88.7%$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
-1.6%		N/A-29.0%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.08
+9.1%		N/A-37.5%$0.00$5.61MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SLXNW) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel
The trading strategy that works BECAUSE you have a life
Tim Sykes built a trading strategy for people who can't watch charts from 9:30 to 4:00 every day. It's not ...
Tim Sykes | Sponsoredtc pixel